Zacks Investment Research on MSN20h
CytomX Therapeutics (CTMX) Upgraded to Strong Buy: Here's What You Should KnowCytomX Therapeutics (CTMX) could be a solid choice for investors given its recent upgrade to a Zacks Rank #1 (Strong Buy). This upgrade primarily reflects an upward trend in earnings estimates, which ...
Analysts are showing growing confidence in European and Chinese tech stocks as they outperform the S&P 500 (SPX). Many ...
Durect (DRRX) could be a solid choice for investors given its recent upgrade to a Zacks Rank #1 (Strong Buy). This upgrade is essentially a reflection of an upward trend in earnings estimates ...
PennantPark (PFLT) could be a solid addition to your portfolio given its recent upgrade to a Zacks Rank #1 (Strong Buy). An upward trend in earnings estimates -- one of the most powerful forces ...
In a report released today, Joon Lee from Truist Financial maintained a Buy rating on Solid Biosciences (SLDB – Research Report). The company’s ...
Upgrade Apple Inc. to .Strong Buy. Click to see why AAPL stock is a bargain despite challenges! Explore future innovations & growth potential.
Zacks Investment Research on MSN20h
Veeva (VEEV) Upgraded to Strong Buy: Here's WhyVeeva Systems (VEEV) could be a solid choice for investors given its recent upgrade to a Zacks Rank #1 (Strong Buy). This upgrade primarily reflects an upward trend in earnings estimates, which is one ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback